Evaluation of immunotherapy for idiopathic membranous nephropathy based on risk stratification and pathological stage

Yang Yang1, Yuxin Zhang2, Ran Zhang3

  • 1Department of Nephrology, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, P. R. China; Jiangxi Key Laboratory of Molecular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, P. R. China.

Abstract

Related Concept Videos